Celastrol Ameliorates Inflammation in Human Retinal Pigment Epithelial Cells by Suppressing NF-κB Signaling

Celastrol Ameliorates Inflammation in Human Retinal Pigment Epithelial Cells by Suppressing NF-κB Signaling
复制标题

雷公藤红素通过抑制 NF-κB 信号传导改善人视网膜色素上皮细胞的炎症

DOI:
10.1089/jop.2018.0092
复制
发表时间:
2019
影响因子:
2.3
通讯作者:
Fu Shang
Fu Shang
中科院分区:
医学4区
文献类型:
--
作者:
Jingyue Zhang;Kewen Zhou;Xinyu Zhang;Yeqi Zhou;Zhen Li;Fu Shang

文献摘要

相似文献

目的:雷公藤红素是一种三萜奎宁类化合物,对多种疾病模型具有重要的生物学作用。在这项研究中,我们的目的是评估celastrol抑制脂多糖(LPS)诱导的视网膜色素上皮(RPE)细胞炎症的能力。方法:对人RPE (HRPE)细胞和ARPE-19细胞株进行单独或联合LPS处理。采用CCK-8法检测雷公藤红素对RPE细胞的细胞毒作用。通过流式细胞术和实时荧光定量PCR分别检测炎症细胞因子IL-6、IL-8和MCP-1的蛋白和mRNA水平。western blotting检测NF-κB信号通路磷酸化中间体(如i -κB α/β和p65)和MAPK信号通路磷酸化中间体(p38MAPK、SAPK/JNK和p42/p44MAPK)的水平。结果:在HRPE和ARPE-19细胞中,Celastrol显著抑制lps诱导的促炎细胞因子IL-6、IL-8和MCP-1的蛋白表达和mRNA表达水平。细胞活力和凋亡实验表明,在浓度小于1 μM时,celastrol对RPE细胞无明显的细胞毒作用,对RPE细胞凋亡有抑制作用。从机制上说,用celastrol预处理的RPE细胞表现出NF-κB通路调节因子、IKKα/β和i -κB α的磷酸化显著降低,随后P65失活,这表明celastrol通过抑制NF-κB信号通路来改善lps诱导的炎症。结论:雷公藤红素对RPE细胞具有较强的抗炎作用,在老年性黄斑变性的防治中具有潜在的应用价值。
Purpose:Celastrol is a triterpenoid quinine methide that exerts important biological effects on a variety of disease models. In this study, we aim to assess the ability of celastrol to inhibit lipopolysaccharide (LPS)-induced inflammation in retinal pigment epithelial (RPE) cells.Methods:Primary cultures of human RPE (HRPE) cells and ARPE-19 cell lines were treated with celastrol alone or in combination with LPS. The cytotoxic effect of celastrol on RPE cells was determined by the CCK-8 assay. Protein and mRNA levels of inflammatory cytokines, including IL-6, IL-8, and MCP-1, were detected by flow cytometry or by real-time fluorescent quantitative PCR, respectively. The levels of phosphorylated intermediates in the NF-κB signaling pathway (such as IκBα/β and p65) and MAPK signaling pathway (p38MAPK, SAPK/JNK, and p42/p44MAPK) were detected by western blotting.Results:Celastrol significantly inhibited LPS-induced expression of protein and mRNA expression levels encoding the proinflammatory cytokines, IL-6, IL-8, and MCP-1, in both HRPE and ARPE-19 cells. Cell viability and apoptosis assays revealed that celastrol had no apparent cytotoxic effect and it inhibited apoptosis of RPE cells at concentrations of less than 1 μM. Mechanistically, RPE cells that were pretreated with celastrol exhibited a substantial decrease in phosphorylation of the NF-κB pathway regulators, IKKα/β and IκBα, and subsequently inactivated P65, suggesting that celastrol ameliorates LPS-induced inflammation by suppressing the NF-κB signaling pathway.Conclusion:Our results provide evidence that celastrol is a potent anti-inflammatory agent in RPE cells and it may have potential applications in prevention and treatment of age-related macular degeneration.